Haemoglobin binding of a musk xylene metabolite in man

Xenobiotica

Volumn 29, Issue 6, 1999, Pages 573-582

  Riedel, Jens ^a   Birner, Gerhard ^a   Van Dorp, Corinne ^a   Neumann, Hans Günter ^a   Dekant, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MUSK XYLENE;

ARTICLE; BIOAVAILABILITY; BIOTRANSFORMATION; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; MASS SPECTROMETRY; NORMAL HUMAN; POLLUTANT; POLLUTION; REDUCTION;

ADULT; ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HUMANS; MALE; PERFUME; PROTEIN BINDING; RATS; RATS, WISTAR; XYLENES;

ANIMALIA;

EID: 0032781444     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238399     Document Type: Article

References (26)

1. ALBRECHT, W. and NEUMANN, H. G., 1985, Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts. Archives of Toxicology, 57, 1-5.
2. API, A. M.,FORD, R.A. and SAN, R.H.C., 1995, An evaluation of musk xylene in a battery of genotoxicity tests. Food and Chemical Toxicology, 33, 1039 1045.
3. BIRNER, G. and NEUMANN, H. G., 1988, Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines. Archives of Toxicology, 62, 110-115.
4. EMIG, M., REINHARDT, A. and MERSCH-SUNDERMANN, V., 1996, A comparative study of five nitro musk compounds for genotoxicity in the SOS chromotest and Salmonella mutagenicity. Toxicology Letters, 85, 151-156.
5. FARMER, P. B., NEUMANN, H.-G. and HENSCHLER, D., 1987, Estimation of exposure of man to substances reacting covalently with macromolecules. Archives of Toxicology, 60, 251-260.
6. HELBLING, K. S., SCHMID, P. and SCHLATTER, C., 1994, The trace analysis of musk xylene in biological samples: problems associated with its ubiquitous occurrence. Chemosphere, 29, 477-484.
7. KOKOT-HELBLING, 1995, Critical kinetic aspects of lipophilic compounds. 1 Volatile organic compounds as food contaminants. lI. Musk xylene in humans and laboratory animals. Naturwissenschaftliche Dissertation an der ETH Zürich.
8. LEHMAN-MCKEEMAN, L. D., CAUDILL, D., YOUNG, J. A. and DIERCKMAN, T. A., 1995, Musk xylene induces and inhibits mouse hepatic cytochrome P-450 2B enzymes. Biochemical and Biophysical Research Communications, 206, 975-980.
9. LEHMAN-MCKEEMAN, L. D., JOHNSON, D. R. and CAUDILL, D., 1997a, Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene. Toxicology and Applied Pharmacology, 142, 169-177.
10. LEHMAN-MCKEEMAN, L. D., JOHNSON, D. R., CAUDILL, D. and STUARD, S. B., 1997b, Mechanism based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene. Drug Metabolism and Disposition, 25, 384-389.
11. LIEBL, B. and EHRENSTOFER, S., 1993, Nitromoschusverbindungen in der Frauenmilch. Gesundheitswesen, 55, 527-532.
12. MAEKAWA, A., MATSUSHIMA, Y., ONODERA, H., SHIBUTANI, M., OGASAWARA, H., KODAMA, Y., KUROKAWA, Y. and HAYASHI, Y., 1990, Long-term toxicity/carcinogenicity of musk xylol in B6C3F1 mice. Food and Chemical Toxicology, 28, 581-586.
13. MINEGISHI, K., NAMBARU, S., FUKUOKA, M., TANAKA, A. and NISHIMAKI-MOGAMI, T., 1991, Distribution, metabolism, and excretion of musk xylene in rats. Archives of Toxicology, 65, 273-282.
14. MÜLLER, S., SCHMID, P. and SCHLATTER, C., 1996, Occurrence of nitro and non-nitro benzenoid musk compounds in human adipose tissue. Chemosphere, 33, 17-28.
15. NEUMANN, H. G., 1984, Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Archives of Toxicology, 56, 1-6.
16. NEUMANN, H. G., ALBRECHT, O., VAN DORP, C. and ZWlRNER-BAIER, I., 1995, Macromolecular adducts caused by environmental chemicals. Clinical Chemistry, 41, 1835-1840.
17. NEUMANN, H. G., BIRNER, G., KOWALLIK, P., SCHUTZE, D. and ZWIRNER-BAIER, I., 1993, Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment. Environmental Health Perspectives, 99, 65 69.
18. PEREIRA, M. A., LIN, L.-H. C. and CHANG, L. W., 1981, Dose-dependence of 2-acetylaminofluorene binding to liver DNA and hemoglobin in mice and rats. Toxicology and Applied Pharmacology, 60, 472-478.
19. PUTMAN, D. I., FORD, R. A., API, A. M., BIGGER, C. A., SAN, R. H. C. and JACOBSON-KRAM, D., 1993, An evaluation of musk xylene in a battery of short-term genotoxicity tests. Toxicologist, 13, 222.
20. RIMIKUS, G. and WOLF, M., 1993, Nachweis von Nitromoschusverbindungen in Frauenmilch und Humanfett. Dtsch. Lebensmittel-Rundschau, 4, 103-107.
21. SABBIONI, G., 1992, Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for N-oxidation. Chemico-Biological Interactions, 81, 91-117.
22. SABBIONI, G., 1994, Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships. Environmental Health Perspectives, 6, 61-67.
23. SKIPPER, P. L., PENG, X., SOOHOO, C. K. and TANNENBAUM, S. R., 1994, Protein adducts as biomarkers of human carcinogen exposure. Drug Metabolivm Reviews, 26, 111-124.
24. SKIPPER, P. L. and TANNENBAUM, S. R., 1994, Molecular dosimetry of aromatic amines in human populations. Environmental Health Perspectives, 6, 17-21.
25. TANNENBAUM, S. R. and SKIPPER, P. L., 1994, Quantitative analysis of hemoglobin-xenobiotic adducts. Methods in Enzymology, 231, 625-632.
26. ZWIRNER-BAIER, I. and NEUMANN, H.-G., 1998, Biomonitoring of aromatic amines: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by hemoglobin binding. Archives of Toxicology 172, 499-504.